These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 21931118)
21. [Detection, enrichment and expansion of T lymphocytes mediating alloresponse based on cytokine]. Meng XJ; Lin MF; Cai Z Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 35(1):39-44. PubMed ID: 16470919 [TBL] [Abstract][Full Text] [Related]
24. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Bosè F; Raeli L; Garutti C; Frigerio E; Cozzi A; Crimi M; Caprioli F; Scavelli R; Altomare G; Geginat J; Abrignani S; Reali E Clin Immunol; 2011 May; 139(2):164-76. PubMed ID: 21334981 [TBL] [Abstract][Full Text] [Related]
25. Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314. Kircheis R; Halanek N; Koller I; Jost W; Schuster M; Gorr G; Hajszan K; Nechansky A MAbs; 2012; 4(4):532-41. PubMed ID: 22665069 [TBL] [Abstract][Full Text] [Related]
26. An additional CD28 costimulatory signal enhances proliferation and cytotoxicity of murine T cell-derived CIK cell. Timalsena S; Pluangnooch P; Wongkajornsilp A; Soontrapa K Asian Pac J Allergy Immunol; 2017 Jun; 35(2):67-74. PubMed ID: 27543727 [TBL] [Abstract][Full Text] [Related]
27. CD28 signals the differential control of regulatory T cells and effector T cells. Mikami N; Sakaguchi S Eur J Immunol; 2014 Apr; 44(4):955-7. PubMed ID: 24652756 [TBL] [Abstract][Full Text] [Related]
28. The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account. Hünig T FEBS J; 2016 Sep; 283(18):3325-34. PubMed ID: 27191544 [TBL] [Abstract][Full Text] [Related]
29. Different players generate positive responses in two in vitro cytokine assay formats with aqueous and immobilized TGN1412 analog. Iwata Y; Harada A; Kubo C; Inoue T; Tabo M; Mishima M Biochem Biophys Res Commun; 2018 Jul; 502(1):91-97. PubMed ID: 29787754 [TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 spike protein induces the cytokine release syndrome by stimulating T cells to produce more IL-2. Niu C; Liang T; Chen Y; Zhu S; Zhou L; Chen N; Qian L; Wang Y; Li M; Zhou X; Cui J Front Immunol; 2024; 15():1444643. PubMed ID: 39359733 [TBL] [Abstract][Full Text] [Related]
31. An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability Urbano PCM; Koenen HJPM; Joosten I; He X Front Immunol; 2018; 9():573. PubMed ID: 29619032 [TBL] [Abstract][Full Text] [Related]
32. [Co-stimulation of multiple activating factors on proliferation and phenotype of T lymphocytes in peripheral blood in vitro]. Liu JQ; Zhu Y; Chen FX; Zhang NZ; Lv XT; Zhou ZH; Zhang J; Zhang S; Tao ZZ; Li Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):367-70. PubMed ID: 22482405 [TBL] [Abstract][Full Text] [Related]
33. Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm. Panoskaltsis N; McCarthy NE; Stagg AJ; Mummery CJ; Husni M; Arebi N; Greenstein D; Price CL; Al-Hassi HO; Koutinas M; Mantalaris A; Knight SC Cancer Immunol Immunother; 2021 Apr; 70(4):1127-1142. PubMed ID: 33033851 [TBL] [Abstract][Full Text] [Related]
34. From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis. Tyrsin D; Chuvpilo S; Matskevich A; Nemenov D; Römer PS; Tabares P; Hünig T Clin Exp Rheumatol; 2016; 34(4 Suppl 98):45-8. PubMed ID: 27586803 [TBL] [Abstract][Full Text] [Related]
35. Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19. Klein SC; Boer LH; de Weger RA; de Gast GC; Bast EJ Scand J Immunol; 1997 Nov; 46(5):452-8. PubMed ID: 9393627 [TBL] [Abstract][Full Text] [Related]
36. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial. Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696 [TBL] [Abstract][Full Text] [Related]
37. Development of a flow cytometry-based potency assay for prediction of cytokine storms induced by biosimilar monoclonal antibodies. Madsen NH; Gad M; Larsen J J Immunol Methods; 2022 Mar; 502():113231. PubMed ID: 35122772 [TBL] [Abstract][Full Text] [Related]
38. Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Karanikas V; Lodding J; Maino VC; McKenzie IF Clin Cancer Res; 2000 Mar; 6(3):829-37. PubMed ID: 10741704 [TBL] [Abstract][Full Text] [Related]
39. Endothelial cells co-stimulate peripheral blood mononuclear cell responses to monoclonal antibody TGN1412 in culture. Findlay L; Sharp G; Fox B; Ball C; Robinson CJ; Bird C; Stebbings R; Eastwood D; Wadhwa M; Poole S; Thorpe R; Thorpe SJ Cytokine; 2011 Jul; 55(1):141-51. PubMed ID: 21493088 [TBL] [Abstract][Full Text] [Related]
40. The co-stimulation of anti-CD28 and IL-2 enhances the sensitivity of ELISPOT assays for detection of neoantigen-specific T cells in PBMC. Tang Y; Zhu L; Xu Q; Zhang X; Li B; Lee LJ J Immunol Methods; 2020; 484-485():112831. PubMed ID: 32758496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]